tau-protein

Documents about tau-protein

• Mechanisms of membrane-induced Tau aggregation#468328HAL (France)
• Computational deciphering of the dynamics of the Tau protein in complex with tubulins and impact of phosphorylations#326199HAL (France)
• Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.#891628ClinicalTrials.gov
• A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau#436219HAL (France)
• Contribution of Tau pathology to mitochondrial impairment in neurodegeneration#948366Repositorio de Universidad Autónoma de Chile.
• Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine-Cysteine Interaction#1368293Repositorio UNAB
• Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates#308406Infoscience
• Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy#6920OpenAlex
• Local organization of biological membranes modulates Tau–lipid interactions and fibril formation#274363HAL (France)
• Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma#308169HAL (France)
• Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma#308213HAL (France)
• Metal Binding to Tau Protein: Physiological and Pathological Relevance.#395910NCBI PubMed Central
• 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease#910589ClinicalTrials.gov
• Disease-specific tau polymorphs are associated with unique protein networks across proteinopathies.#1175509NCBI PubMed Central
• First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain#807364ClinicalTrials.gov
• Peptide-mediated inhibition of aberrant chaperone-mediated autophagy in pericytes prevents glioblastoma progression through MAPT/tau secretion#1053570HAL (France)
• PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer’s Disease#1492515HAL (France)
• Simulations of an Extended Tau/Tubulins Interface Reveal a Complex Disorder–Disorder Interplay Mediated by the C-Terminal Tails#460938HAL (France)
• Circulating sphingomyelins correlate with plasma T-tau in cognitively unimpaired older adults at risk of developing Alzheimer's disease#320845Research Online
• A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease#398839HAL (France)
• Quantification of Phosphorylated Tau Protein in Alzheimer's Disease Patients' Fluids With Electrolyte-Gated Organic Transistor Biosensors.#1097784NCBI PubMed Central
• Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases#1421504ClinicalTrials.gov
• Tau Protein-Induced Microtubule Degeneration and Quantum Coherence Disruption: Implications for Memory, Consciousness, and Temporal Integration in Alzheimer’s Disease.#437170NCBI PubMed Central
• Protein Aggregates as Drivers of Receptor Clustering and Pathological Signaling: A Framework Linking Extracellular Amyloid-β to Tau Dysregulation.#659509NCBI PubMed Central
• A β-hairpin mimic built on a fluorinated isoxazoline-β 2,2 -amino acid as a modulator of Tau protein aggregation#408686HAL (France)
• Lysine methylation is an endogenous post-translational modifications of tau protein in human brain and a modulator of aggregation propensity.#659692NCBI PubMed Central
• Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease#1408066ClinicalTrials.gov
• The poly-arginine peptide R18D inhibits amyloid-beta (Aβ) aggregation and Aβ-induced cytotoxicity, reduces intracellular tau aggregation, and exhibits oral bioavailability#1391857Research Online
• Postoperative Delirium in the ICU Setting of an Eastern European Centre#889159ClinicalTrials.gov
• Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer's disease#205460Europe PMC
• Zika virus infection induces a persistent accumulation of Alzheimer’s disease-like Tau phosphorylation in adult immunocompetent mice in association with memory and social behavior impairments#1053440HAL (France)
• Investigation of the Effect of Preoperative Bowel Cleansing on Postoperative Cognitive Impairment#980445ClinicalTrials.gov
• Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)#850816ClinicalTrials.gov
• Voices Of Individuals: Challenges and Experiences Of bvFTD#1089109ClinicalTrials.gov
• The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment#1171009ClinicalTrials.gov
• The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke#802311ClinicalTrials.gov
• Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain#875329ClinicalTrials.gov
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain#1282226ClinicalTrials.gov
• Data related to manuscript: BET protein inhibitor JQ1 reduces inflammation and hippocampal amyloid-β level without altering Tau phosphorylation in LPS-challenged adult wild-type mice#233007RepOD Dataverse OAI Archive
• The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31#981361ClinicalTrials.gov
• Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease#948645Repositorio de Universidad Autónoma de Chile.
• 14-3-3σ up-regulation in the temporal cortex associates with tau pathology and reactive astroglia in Lewy body disorders#5409Europe PMC
• Search strategy for Blood biomarkers of structural brain injury for prediction of outcomes and detection of complications in aneurysmal subarachnoid hemorrhage#204972Borealis Dataverse OAI Archive
• Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain#1186219ClinicalTrials.gov
• Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults#1363028ClinicalTrials.gov
• Measurement of Tau Protein and Aβ Amyloid Plaques in Postmortem Human Brains of Down Syndrome and Alzheimer's Disease by Using [ 125 I]IPPI and [ 125 I]IBETA Autoradiography#1312124Europe PMC
• Data supporting the publication “Tiny Droplets, Large Insights: Studying Peptide Aggregation with Droplet-based Microfluidics Hyphenated with Ion Mobility Mass Spectrometry”#207987Yoda MOAI Feed
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies#1340337ClinicalTrials.gov